Novacyt S.A.

Novacyt S.A.verified

NVYTF

Price:

$0.51

Market Cap:

$27.60M

Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segme...[Read more]

Industry

Medical - Devices

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

NVYTF

The Enterprise Value as of December 2025 (TTM) for Novacyt S.A. (NVYTF) is 9.02M

According to Novacyt S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.02M. This represents a change of -243.84% compared to the average of -6271392.30 of the last 4 quarters.

Novacyt S.A. (NVYTF) Historical Enterprise Value (quarterly & annually)

How has NVYTF Enterprise Value performed in the past?

The mean historical Enterprise Value of Novacyt S.A. over the last ten years is 77.90M. The current 9.02M Enterprise Value has changed 1.06% with respect to the historical average. Over the past ten years (40 quarters), NVYTF's Enterprise Value was at its highest in in the June 2020 quarter at 169.39M. The Enterprise Value was at its lowest in in the December 2020 quarter at -89387000.00.

Quarterly (TTM)
Annual

Average

77.90M

Median

16.62M

Minimum

-9328464.63

Maximum

508.27M

Novacyt S.A. (NVYTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Novacyt S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.17%

Maximum Annual Enterprise Value = 508.27M

Minimum Annual Increase = -242.42%

Minimum Annual Enterprise Value = -9328464.63

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202416.61M25.05%
202313.29M-242.42%
2022-9328464.63-105.82%
2021160.32M-68.46%
2020508.27M3.17%
201915.54M-15.71%
201818.44M10.88%
201716.63M1.19%
201616.43M-27.90%
201522.79M12.28%

Novacyt S.A. (NVYTF) Average Enterprise Value

How has NVYTF Enterprise Value performed in the past?

The current Enterprise Value of Novacyt S.A. (NVYTF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

6.86M

5-year avg

137.83M

10-year avg

77.90M

Novacyt S.A. (NVYTF) Enterprise Value vs. Peers

How is NVYTF’s Enterprise Value compared to its peers?

Novacyt S.A.’s Enterprise Value is less than Theralase Technologies Inc. (42.61M), less than Vivos Inc. (30.94M), greater than Drug Free Solution, Inc. (476.40K), less than Medical Developments International Limited (45.55M), less than PetVivo Holdings, Inc. (26.06M), less than Nova Eye Medical Limited (37.84M), less than iAnthus Capital Holdings, Inc. (236.77M), less than The Cannabist Company Holdings Inc. (446.45M), less than ImpediMed Limited (69.73M), less than Sernova Corp. (48.76M),

Build a custom stock screener for Novacyt S.A. (NVYTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novacyt S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novacyt S.A. (NVYTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novacyt S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Novacyt S.A.'s Enterprise Value?

What is the highest Enterprise Value for Novacyt S.A. (NVYTF)?

What is the 3-year average Enterprise Value for Novacyt S.A. (NVYTF)?

What is the 5-year average Enterprise Value for Novacyt S.A. (NVYTF)?

How does the current Enterprise Value for Novacyt S.A. (NVYTF) compare to its historical average?